| 000 | 01868 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514025726.0 | ||
| 264 | 0 | _c20020924 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFurst, Daniel E | |
| 245 | 0 | 0 |
_aDose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cMar 2002 |
||
| 300 |
_a436-46 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aDiclofenac _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMeloxicam |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aProstaglandin-Endoperoxide Synthases |
| 650 | 0 | 4 |
_aThiazines _xadministration & dosage |
| 650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKolba, Karen S | |
| 700 | 1 | _aFleischmann, Roy | |
| 700 | 1 | _aSilverfield, Joel | |
| 700 | 1 | _aGreenwald, Maria | |
| 700 | 1 | _aRoth, Sanford | |
| 700 | 1 | _aHall, David B | |
| 700 | 1 | _aRoszko, Paul J | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 29 _gno. 3 _gp. 436-46 |
|
| 999 |
_c11814075 _d11814075 |
||